DrugPatentWatch Database Preview

Takeda Pharms Usa Company Profile

« Back to Dashboard

What is the competitive landscape for TAKEDA PHARMS USA, and when can generic versions of TAKEDA PHARMS USA drugs launch?

TAKEDA PHARMS USA has seventeen approved drugs.

There are eighty-two US patents protecting TAKEDA PHARMS USA drugs.

There are one thousand and sixty-five patent family members on TAKEDA PHARMS USA drugs in fifty-eight countries and one hundred and eight supplementary protection certificates in fifteen countries.

Summary for Takeda Pharms Usa

International Patents:	1065
US Patents:	82
Tradenames:	17
Ingredients:	14
NDAs:	17

Drugs and US Patents for Takeda Pharms Usa

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Takeda Pharms Usa	TRINTELLIX	vortioxetine hydrobromide	TABLET;ORAL	204447-004	Sep 30, 2013		RX	Yes	Yes
Takeda Pharms Usa	DEXILANT	dexlansoprazole	CAPSULE, DELAYED RELEASE;ORAL	022287-002	Jan 30, 2009	AB	RX	Yes	Yes	8,105,626*PED				Y
Takeda Pharms Usa	ACTOPLUS MET XR	metformin hydrochloride; pioglitazone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022024-002	May 12, 2009		RX	Yes	Yes	9,060,941		Y
Takeda Pharms Usa	OMONTYS PRESERVATIVE FREE	peginesatide acetate	SOLUTION;INTRAVENOUS, SUBCUTANEOUS	202799-005	Mar 27, 2012		DISCN	No	No	7,414,105		Y	Y

Expired US Patents for Takeda Pharms Usa

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Usa	NESINA	alogliptin benzoate	TABLET;ORAL	022271-002	Jan 25, 2013	6,150,383
Takeda Pharms Usa	OSENI	alogliptin benzoate; pioglitazone hydrochloride	TABLET;ORAL	022426-001	Jan 25, 2013	7,078,381
Takeda Pharms Usa	NESINA	alogliptin benzoate	TABLET;ORAL	022271-001	Jan 25, 2013	7,078,381
Takeda Pharms Usa	NESINA	alogliptin benzoate	TABLET;ORAL	022271-003	Jan 25, 2013	6,150,383

Paragraph IV (Patent) Challenges for TAKEDA PHARMS USA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-release Capsule	30 mg		2010-11-30
	Tablets	15 mg/500 mg and 15 mg/850 mg		2008-03-06
	Tablets	30 mg/2 mg and 30 mg/4 mg		2009-12-22
	Tablets	6.25 mg, 12.5 mg and 25 mg		2017-01-25
	Tablets	5 mg, 10 mg, 15 mgand 20 mg		2017-10-02
	Delayed-release Pellets/Capsul	15 mg and 30 mg		2005-12-05
	Capsule	60 mg		2010-08-25
	Extended-release Tablets	15 mg/1000 mg and 30 mg/1000 mg		2011-09-23
	Tablets	0.6 mg		2011-12-23
	Tablets	12.5 mg/500 mg and 12.5 mg/1000 mg		2017-01-25
	Tablets	8 mg		2009-07-22
	Tablets	40 mg and 80 mg		2013-02-13
	Delayed-release Orally Disinte	15 mg and 30 mg		2006-12-27

International Patents for Takeda Pharms Usa Drugs

Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	200501798
Japan	5022893
European Patent Office	2431039
Argentina	093609

Supplementary Protection Certificates for Takeda Pharms Usa Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1412357	77 5006-2008	Slovakia		PRODUCT NAME: SITAGLIPTIN A METFORMIN; NAT. REG.NO/DATE: EU/1/08/455/001-014, EU/1/08/456/001-014, EU/1/08/457/001-014 20080716; FIRST REG.:CH 58450 01-03 20080408
1129088	2014C/017	Belgium		PRODUCT NAME: DEXLANSOPRAZOL; AUTHORISATION NUMBER AND DATE: 47911 20131023
1586571	92374	Luxembourg		PRODUCT NAME: ALOGLIPTIN SOUS TOUTES SES FORMES TELLES QUE PROTEGEES PAR LE BREVET DE BASE. FIRST REGISTRATION: 20130923
1084705	PA2014045	Lithuania		PRODUCT NAME: ALOGLIPTINUM; REGISTRATION NO/DATE: EU/1/13/844/001-027 20130919

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Takeda
• Takeda Pharms Na
• Takeda Pharms Usa